GlassScriptPhysician profile
Ashley G Black
NPI 1316254139
$45,712.85
in general payments reported to CMS, 2019-2025
33 companies · $29K in 2025
The $29K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,146 · 2020: $286 · 2021: $315 · 2022: $11K · 2023: $2,158 · 2024: $2,347 · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Consulting Fee: $11K · Food and Beverage: $3,458 · Travel and Lodging: $622 · Education: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,136.00 |
| Consulting Fee | $10,595.00 |
| Food and Beverage | $3,458.07 |
| Travel and Lodging | $622.37 |
| Education | $203.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $29,044.79 | 2021-2025 | |
| Intuitive Surgical, INC. | $11,645.34 | 2022-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,354.07 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Verathon INC. | $1,000.00 | 2025 | Bronoscope |
| Inari Medical, INC. | $390.36 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.66 | 2019-2024 | Ofev |
| Astrazeneca Pharmaceuticals LP | $281.78 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $224.14 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $205.43 | 2021-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $117.10 | 2024 | Uptravi, Opsumit |
| Abiomed | $109.48 | 2023 | Impella |
| Electromed, INC. | $104.91 | 2019-2025 | Smartvest |
| Livanova USA, INC. | $104.02 | 2023 | Lifesparc |
| Sanofi-Aventis U.S. LLC | $99.95 | 2024 | |
| Insmed, INC. | $86.91 | 2025 | Arikayce, Brinsupri |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $82.78 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Merck Sharp & Dohme LLC | $65.76 | 2019-2025 | Zerbaxa |
| Genentech USA, INC. | $64.14 | 2019-2022 | |
| Mylan Specialty L.P. | $59.58 | 2019-2020 | |
| Circassia INC. | $47.68 | 2025 | Niox |
| Siemens Medical Solutions USA, INC. | $41.54 | 2025 | Cios Spin |
| Inogen, INC. | $39.54 | 2025 | |
| Shionogi INC | $33.03 | 2024 | Fetroja |
| Amgen INC. | $32.16 | 2024-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $24.82 | 2025 | Glassia |
| Ambu INC. | $24.43 | 2023 | |
| Grifols USA, LLC | $23.28 | 2025 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $23.22 | 2023 | Inspire |
| Tactile Systems Technology INC | $22.98 | 2025 | Nimbl, Flexitouch Plus |
| Chiesi USA, INC. | $18.33 | 2020 | |
| Pulmonx Corporation | $16.74 | 2019 | |
| Allergan, INC. | $16.36 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.